Thalassemic mutations in southern Iran

Iranian Journal of Medical Sciences

Volumn 31, Issue 2, 2006, Pages 70-73

  Rahimi, Z ^a,b   Raygani, A Vaisi ^b   Merat, A ^c   Haghshenass, M ^d   Gerard, N ^e   Nagel, R L ^f   Krishnamoorthy, R ^e  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e HÔPITAL ROBERT DEBRÉ   (France)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Heterogenous; Iran; Mutations; Sickle cell; thalassemia

Indexed keywords

BETA GLOBIN; NUCLEOTIDE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BASE PAIRING; BETA THALASSEMIA; CHILD; CHROMOSOME DELETION; CHROMOSOME MUTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DOT HYBRIDIZATION; FEMALE; GENE SEQUENCE; HEMATOLOGY; HETEROZYGOSITY; HUMAN; INTRON; MALE; SICKLE CELL;

EID: 33744950688     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Tadmouri GO, Bilenoglu O, Kantarci S, et al. A rare mutation [IVS-I-1 30 (G-A)] in a Turkish β- thlassemia major patient. Am J Hematol 2000; 63: 223-5.
2. Diaz-Chico JC, Yang KG, Yang KY, et al. The detection of β-globin gene mutations in β-thalassemia using oligonucleotide probes and amplified DNA. Biochem Biophys Acta 1988; 949: 43-8.
3. th ed. New York; McGraw-Hill; 2001. p. 547-80.
4. Najmabadi H, Teimourian Sh, Khatibi T, et al. Amplification refractory mutation system (ARMS) and reverse hybridization in the detection of beta thalassemia mutations. Arch Irn Med 2001; 4: 165-70.
5. Karimi M, Alavian Ghavanini A, Kadivar MR. Regional mapping of the gene frequency of β- thlassemia in Fars province, Iran during 1997-1998. Iran J Med Sci 2000; 25: 134-7.
6. Merat A, Haghshenass M, Pour ZM, et al. β-thalassemia in Southwestern Iran. Hemoglobin 1993; 17: 427-37.
7. Karimi M, Yarmohammadi H, Farjadian S, et al. Beta-thalassemia intermedia from southern Iran: IVSII-I(G:A) is the prevalent thalassemia intermedia allele. Hemoglobin 2002; 26: 147-54.
8. Najmabadi H, Karimi-Nejad R, Sahebjam S, et al. The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin 2001; 25: 285-96.
9. Betke K, Marti HR, Schlict I. Estimation of small percentages of fetal haemoglobin. Nature 1959; 184: 1877-8.
10. Fairbanks VF, Klee GG. Biochemical aspects of hematology. In: Burtis CA, Ashwood ER, editors: Tietz text book of clinical chemistry. Philadelphia: W.B Saunders; 1994. p. 2041-2.
11. 2, C, E, and O by electrophoresis of the globin chains. Clin Chem 1974; 20: 1111-5.
12. Old JM, Higgs DR. Gene analysis. In Weatherall DJ, editor: Methods in Haematology. The thalassemias. Vol 6. Livingstone; 1983. p. 74-101.
13. Sutcharitchan P, Saiki R, Huisman TH, et al. Reverse dot-blot detection of the African-American β-thalassemia mutations. Blood 1995; 86: 1580-5.
14. Cai SP, Wall J, Kan YW, Chehab FF. Reverse dot blot probes for the screening of β -thalassemia mutations in Asian and American blacks. Hum Mutat 1994; 3: 59-63.
15. Ghanem N, Girodon E, Vidaud M, et al. A comprehensive scanning method for rapid detection of β-globin gene mutations and polymorphisms. Hum Mutat 1992; 1: 229-39.
16. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain termination inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-9.
17. Murru S, Loudianos G, Deiana M, et al. Molecular characterization of β-thalassemia intermedia in patients of Italian descent and identification of three novel β-thalassemia mutations. Blood 1991; 77: 1342-7.
18. Jassim N, Merghoub T, Pascaud O, et al. Molecular basis of β-thalassemia in Bahrain: An epicentre for a Middle East specific mutation. Ann NY Acad Sci 1998; 850: 407-9.